Showing results (1311-1320 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|October 9, 2002
Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patientsJürgen Kurt Rockstroh, Mannah Mudar, Mathias Lichterfeld, et al.AIDS (London, England)|October 9, 2002
HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonateRana Chakraborty, Geraldine M A Gillespie, Milan Reinis, et al.AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.AIDS (London, England)|September 28, 2002
Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progressionSilvina Masciotra, Sherry M Owen, Donna Rudolph, et al.AIDS (London, England)|September 28, 2002
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 cladesThomas G Bird, Rupert Kaul, Timothy Rostron, et al.AIDS (London, England)|September 28, 2002
HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brainGuido Van Marle, Sean B Rourke, Kunyan Zhang, et al.AIDS (London, England)|September 28, 2002
Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortalityWafaie W Fawzi, Gernard I Msamanga, David Hunter, et al.AIDS (London, England)|May 11, 2002
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormoneLaura A Napolitano, Joan C Lo, Michael B Gotway, et al.AIDS (London, England)|May 11, 2002
Use of laboratory tests and clinical symptoms for identification of primary HIV infectionFrederick M Hecht, Michael P Busch, Bhupat Rawal, et al.AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.Pageof 1,044